BR vs FISV: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: FISV is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BR and FISV share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BR and FISV exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Spun out of ADP in 2007, Broadridge runs two businesses that most investors interact with without knowing it. Investor Communication Solutions, ~$5.56 billion of fiscal 2026 revenue, distributes the proxy statements, annual reports, prospectuses and account communications that brokers are legally required to deliver, and it collects a fee per position delivered. Global Technology and Operations, ~$1.92 billion, runs the back-office trade processing, clearing support and wealth platforms behind large broker-dealers, including fixed income processing for 22 of the 26 U.S. primary dealers. A meaningful chunk of reported revenue (~$2.25 billion in fiscal 2026) is distribution revenue, largely postage passed through at little or no margin, so headline growth flatters the underlying economics. The metric management runs on is recurring revenue, ~$4.88 billion in fiscal 2026 and up ~8% in constant currency.

Full BR guide

Fiserv is one of the largest payments and financial-technology companies in the world. It operates broadly in two areas: merchant solutions, where it processes card and digital payments for millions of businesses and runs the Clover point-of-sale and small-business platform, and financial solutions, where it provides core account processing, card issuing, digital banking, and related technology to banks and credit unions. Most of its revenue is recurring and transaction-based, tied to the volume of payments and accounts it processes, which gives the business a steady, infrastructure-like quality. Fiserv changed its listing to the Nasdaq and reinstated its original ticker symbol FISV (from FI) in November 2025.

Full FISV guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BR drivers: Regulatory position growth compounds without new sales; Wealth and capital markets consolidation via tuck-in deals.
• FISV drivers: Recurring, transaction-based revenue; Clover platform growth.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Regulatory dependence cuts both ways: a large share of Investor Communication Solutions revenue exists because SEC rules and NYSE-approved fee schedules mandate delivery and set the rate, so any rework of proxy fees, e-delivery rules or shareholder communication requirements hits the highest-margin part of the business directly. For FISV, the main risk is that Fiserv's growth is modest, so slowing organic revenue growth, margin pressure, or weaker free cash flow can disappoint investors, as the 2026 share weakness showed.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BR if you believe its drivers more; FISV if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BR and FISV guides.

BR. Reported earnings need a second look this year, because GAAP diluted EPS of ~$9.60 and adjusted EPS of ~$9.60 landed at the same number by coincidence: GAAP was lifted by ~$227 million of non-cash digital asset gains while adjusted results excluded them and added back acquisition amortization. Measured on the recurring base, growth was ~8% with adjusted operating margin flat at ~20.5%, since postage-driven distribution revenue and lower float income each diluted the mix. The multiple has compressed toward the low end of Broadridge's historical range even as fiscal 2027 guidance calls for ~8% to ~12% adjusted EPS growth.

FISV. Figures are approximate and tied to the asOf date; verify live numbers before acting. Fiserv is a profitable, cash-generative company, so an earnings multiple is meaningful, and the 2026 share weakness left some valuation metrics looking discounted versus its history. But the market's concern is the pace of organic growth, margins, and free-cash-flow recovery, so investors should weigh those trends and execution on internal initiatives rather than the multiple alone.

Headline figures (approximate, August 2026): BR shows revenue (fy2026, ttm) ~$7.48 billion, up ~9%, recurring revenue ~$4.88 billion, up ~8% constant currency, adjusted eps (fy2026) ~$9.60, up ~12%, free cash flow ~$1.23 billion (~110% conversion); FISV shows revenue (q1 2026) ~$5.03 billion, down about 2% year over year, adjusted eps (q1 2026) ~$1.79, beating expectations though down year over year, gaap eps (q1 2026) ~$1.07, 2026 guidance organic revenue growth ~1% to 3%; adjusted EPS ~$8.00 to $8.30 (reaffirmed).

BR and FISV are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BR and FISV exposure against your real portfolio. It is not an investment adviser.